A mathematical model of tumor-immune evasion and siRNA treatment
From MaRDI portal
Publication:1430340
DOI10.3934/dcdsb.2004.4.39zbMath1083.37531OpenAlexW2029159090MaRDI QIDQ1430340
Denise E. Kirschner, Trachette L. Jackson, Julia C. Arciero
Publication date: 27 May 2004
Published in: Discrete and Continuous Dynamical Systems. Series B (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.3934/dcdsb.2004.4.39
Dynamical systems in biology (37N25) Qualitative investigation and simulation of ordinary differential equation models (34C60) Physiological, cellular and medical topics (92C99) Dimension theory of smooth dynamical systems (37C45)
Related Items
On a discrete model of tumour–immune system interactions with blockade of immune checkpoints, Mathematical modeling of tumor and cancer stem cells treated with CAR-T therapy and inhibition of TGF-\(\beta\), A chaos study of tumor and effector cells in fractional tumor-immune model for cancer treatment, On immunotherapies and cancer vaccination protocols: a mathematical modelling approach, Analysis of the dynamics of a tumor-immune system with chemotherapy and immunotherapy and quadratic optimal control, Stability and bifurcation analysis of delay induced tumor immune interaction model, A cancer treatment based on synergy between anti-angiogenic and immune cell therapies, Modeling the treatment of glioblastoma multiforme and cancer stem cells with ordinary differential equations, Evolutionary paradigm in cancer immunology, Dynamics of a Mathematical Model of Cancer and Immunoediting Scenarios Under the Variation of the Immune Cell Activation Rate, Mathematical modelling for the role of CD\(4^+\)T cells in tumor-immune interactions, Pattern formation in a nonlocal mathematical model for the multiple roles of the TGF-\(\beta\) pathway in tumour dynamics, Existence of periodic solution for a tumor growth model with vaccine interaction, A mathematical model of combined \textit{bacillus Calmette-Guerin} (BCG) and interleukin (IL)-2 immunotherapy of superficial bladder cancer, Ultimate dynamics of the Kirschner-Panetta model: tumor eradication and related problems, A mathematical model of treatment of cancer stem cells with immunotherapy, Modeling pancreatic cancer dynamics with immunotherapy, Optimization therapy by coupling intermittent androgen suppression with impulsive chemotherapy for a prostate cancer model, STOCHASTIC DYNAMICS BETWEEN THE IMMUNE SYSTEM AND CANCER CELLS WITH ALLEE EFFECT AND IMMUNOTHERAPY, Dynamics of tumor-\( \text{CD}4^+\)-cytokine-host cells interactions with treatments, Qualitative and computational analysis of a mathematical model for tumor-immune interactions, A cellular automata model of tumor-immune system interactions, A model of tumor‐immune system interactions with healthy cells and immunotherapies, A set-valued approach to control immunotherapy, Global asymptotic stability of a delay differential equation model for SARS-CoV-2 virus infection mediated by ACE2 receptor protein, Studying the importance of regulatory T cells in chemoimmunotherapy mathematical modeling and proposing new approaches for developing a mathematical dynamic of cancer, Global stability and tumor clearance conditions for a cancer chemotherapy system, Interactions between the immune system and cancer: A brief review of non-spatial mathematical models, New observations on optimal cancer treatments for a fractional tumor growth model with and without singular kernel, A fractional-order delay differential model with optimal control for cancer treatment based on synergy between anti-angiogenic and immune cell therapies, Mathematical modeling on helper T cells in a tumor immune system, Methods for determining key components in a mathematical model for tumor-immune dynamics in multiple myeloma, The four-dimensional Kirschner-Panetta type cancer model: how to obtain tumor eradication?, Modelling lymphoma therapy and outcome, Tumour suppression by immune system through stochastic oscillations, Modeling anti-tumor Th1 and Th2 immunity in the rejection of melanoma, Bounding the dynamics of a chaotic-cancer mathematical model, Bridging blood cancers and inflammation: the reduced cancitis model, Tractable Model of Malignant Gliomas Immunotherapy with Discrete Time Delays, MATHEMATICAL MODELING OF IN-VIVO TUMOR-IMMUNE INTERACTIONS FOR THE CANCER IMMUNOTHERAPY USING MATURED DENDRITIC CELLS, Stochastic hybrid automata with delayed transitions to model biochemical systems with delays, Dynamical behaviour of a tumor-immune system with chemotherapy and optimal control, Diffusive tumor-immune interaction systems under immunotherapy, A structural methodology for modeling immune-tumor interactions including pro- and anti-tumor factors for clinical applications, Dual role of delay effects in a tumour–immune system, Stability and Hopf bifurcations in a competitive tumour-immune system with intrinsic recruitment delay and chemotherapy, Complex dynamics of a tumor-immune system with antigenicity, Optimal control of variable-order fractional model for delay cancer treatments, A mathematical model of the enhancement of tumor vaccine efficacy by immunotherapy, Existence and bifurcation of non-constant positive steady states for a tumor-immune model, Nonlinear dynamics in tumor-immune system interaction models with delays, The dynamical behaviors for a class of immunogenic tumor model with delay, A mathematical model of tumor-immune interactions, A mathematical model of tumor-immune interactions with an immune checkpoint inhibitor, A Feedback Control Model of Comprehensive Therapy for Treating Immunogenic Tumours, Modeling the stem cell hypothesis: investigating the effects of cancer stem cells and TGF \(- \beta\) on tumor growth, A Mathematical Model of Gene Therapy for the Treatment of Cancer, Cancer-induced immunosuppression can enable effectiveness of immunotherapy through bistability generation: a mathematical and computational examination, A stochastic individual-based model to explore the role of spatial interactions and antigen recognition in the immune response against solid tumours, A NEW MATHEMATICAL MODELING AND SUB-OPTIMAL CHEMOTHERAPY OF CANCER, Optimal control for cancer treatment mathematical model using Atangana-Baleanu-Caputo fractional derivative
